EC HEALTHCARE (02138) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

HK Stock MarketDetailed Quotes

02138 EC HEALTHCARE

Watchlist

0.670
-0.010-1.47%

Market Closed Dec 31 12:08 CST

794.09MMarket Cap-67.00P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

EC Healthcare Delays Circular Release to February 2025
TipRanksDec 31, 2024 04:07 ET
EC Healthcare Reveals New Board and Committee Structure
TipRanksDec 27, 2024 06:07 ET
EC Healthcare Welcomes New Non-Executive Director
TipRanksDec 27, 2024 05:08 ET
EC HEALTHCARE (02138.HK): Liang Yang Shidij has been appointed as a non-executive Director.
On December 27th, Gelonghui announced that EC HEALTHCARE (02138.HK) has appointed Liang Yang Shidi (formerly known as Yang Shidi) as the company's non-executive Director, effective from December 27, 2024.
Gelonghui FinanceDec 27, 2024 04:41 ET
EC HEALTHCARE: INTERIM REPORT 2024/25
HKEXDec 20, 2024 03:57 ET · Announcements
EC Healthcare's Subsidiary to Acquire 90% Stake in Cosmetic, Skincare Company
MT NewswiresDec 11, 2024 01:08 ET

Comments

Moomoo AI

Dec 23, 2023 20:43

EC Healthcare's position of paying dividends despite reporting losses over the last year is worrying. However, dividends have been adequately covered by free cash flow. These factors could potentially result in sub-optimal outcomes for dividend investors.

Don't Race Out To Buy EC Healthcare (HKG:2138) Just Because It's Going Ex-Dividend

Moomoo AI

Dec 18, 2023 17:12

EC Healthcare's weak revenue projection and low price-to-sales ratio hint that shareholders may face sluggish share price growth. Despite strong past earnings, the future may not be as promising leading to recent share price drop.

Investors Don't See Light At End Of EC Healthcare's (HKG:2138) Tunnel And Push Stock Down 29%

Moomoo AI

Oct 7, 2023 09:42

The 47% share price fall isn't as bad as the EPS reduction, hinting towards possible recovery optimism reflected in a P/E of 45.09. Unresolved challenges may still persist, inferred from last year's performance surpassing a 5% half-decade loss.